Showing 321-330 of 631 results for "".
New Findings Raise Questions About EHRs Going Forward
https://practicaldermatology.com/topics/practice-management/new-findings-raise-questions-about-ehrs-going-forward/22934/A recently published study dampens expectations for the future of EHRs, which may also signal diminished public support.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-15/23311/Which Probiotic for Which Disease? Part 1
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-1/23550/Enhanced interest in probiotics means clinicians need to pick the best strain for common dermatologic conditions.Diversity and Equity in Dermatology
https://practicaldermatology.com/topics/practice-management/diversity-and-equity-in-dermatology/23456/Pediatric Hidradenitis Suppurativa
https://practicaldermatology.com/topics/rare-disease/pediatric-hidradenitis-suppurativa/56417/A Primer for CliniciansA Practical Approach: Field Treatment of AKs with PDT
https://practicaldermatology.com/issues/supplements/a-practical-approach-field-treatment-of-aks-with-pdt/20431/Why it's essential to treat visible and invisible actinic keratosis lesions and how PDT fits into the treatment armamentarium.Systemic Inflammation in Psoriasis: A Guide for Dermatology Care Providers
https://practicaldermatology.com/topics/psoriasis/systemic-inflammation-in-psoriasis-a-guide-for-dermatology-care-providers/20439/Practical guidance for dermatology care providers on the importance of screening patients with psoriasis for associated comorbidities.Resolution of Primary Erythromelalgia Following Ibuprofen; Fire Power
https://practicaldermatology.com/youngmd-connect/resident-resource-center/resolution-of-primary-erythromelalgia-following-ibuprofen-fire-power/20619/Combination Biologic and GLP-1 Receptor Agonist Therapy in Psoriasis
https://practicaldermatology.com/topics/psoriasis/combination-biologic-and-glp-1-receptor-agonist-therapy-in-psoriasis/60858/New evidence indicates benefits of a dual-treatment strategy for many patients.Management of Atopic Dermatitis During the COVID-19 Pandemic
https://practicaldermatology.com/topics/atopic-dermatitis/management-of-atopic-dermatitis-during-the-covid-19-pandemic/23322/There is concern about the immunosuppressive or immunomodulatory effects of oral and biologic medications in patients with skin disease.